Cite
HARVARD Citation
Corallo, C. et al. (n.d.). SAT0323 The endothelial-to-mesenchymal transition (ENDOMT) in scleroderma can be prevented by the use of dual endothelin receptor antagonists bosentan and macitentan. Annals of the rheumatic diseases. p. 894. [Online].